Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

4.060 +0.040 (+1.00%)
Streaming Delayed Price Updated: 10:18 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Geron Corp

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
15 Stocks Moving in Tuesday's Pre-Market Session
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted... 
Via Benzinga
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
From Geron Corporation
Via Business Wire
Geron Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Geron (NASDAQ:GERN) reported Q2 sales of $107.00 thousand. Earnings fell to a loss of $28.89 million, resulting in a 1.53% decrease from last quarter. Geron... 
Via Benzinga
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Geron Announces September Investor Conference Presentation Webcasts
From Geron Corporation
Via Business Wire
Here's What Investors Need From Geron
It could be a while before Geron has a big catalyst. 
Via The Motley Fool
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron (GERN) Q2 2021 Earnings Call Transcript
GERN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Geron Q2 Earnings
Shares of Geron (NASDAQ:GERN) rose 2.5% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 50.00% over the past year to... 
Via Benzinga
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
From Geron Corporation
Via Business Wire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
Via FinancialNewsMedia
30 Stocks Moving in Friday's Pre-Market Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.9% to $0.839 in pre-market trading after the company reported better-than-expected Q2 sales. The company said it continues to... 
Via Benzinga
Earnings Scheduled For August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to... 
Via Benzinga
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Return On Capital Employed Overview: Geron
During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. Geron collected $50.00 thousand... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5... 
Via Benzinga
58 Biggest Movers From Friday
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.... 
Via Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 1.27% to 33,394.86 while the NASDAQ fell 0.92% to 14,031.05. The S&P also fell, dropping 1.03% to 4,178.31. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge
Midway through trading Friday, the Dow traded down 1.13% to 33,440.28 while the NASDAQ fell 0.74% to 14,056.31. The S&P also fell, dropping 0.92% to 4,183.07. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
32 Stocks Moving In Friday's Mid-Day Session
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... 
Via Benzinga
Why Geron Stock Is Soaring Today
Investors are cheering the company's encouraging phase 2 data. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million.... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures Product Safety
28 Stocks Moving in Friday's Pre-Market Session
Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron... 
Via Benzinga
Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal
Geron Corporation (NASDAQ: GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2 trial of imetelstat for... 
Via Benzinga
Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
From Geron Corporation
Via Business Wire
Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress
From Geron Corporation
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.